Recent Advances in Hantavirus Molecular Biology and Disease

Advances in Applied Microbiology

Volumn 74, Issue , 2011, Pages 35-75

  Hussein, Islam T M ^a   Haseeb, Abdul ^a   Haque, Absarul ^a   Mir, Mohammad A ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; ENVELOPE PROTEIN; GLYCOPROTEIN; HANTAVAX; MESSENGER RNA; NUCLEOCAPSID PROTEIN; RIBAVIRIN; RNA DIRECTED RNA POLYMERASE; TRANSCRIPTASE; UNCLASSIFIED DRUG; VIRUS VACCINE; VIRUS RNA;

BLOOD EXAMINATION; BOOK; BUNYAVIRUS; CELL MIGRATION; CLINICAL TRIAL (TOPIC); ENZYME ACTIVITY; GENETIC TRANSCRIPTION AND TRANSLATION; HANTAVIRUS; HANTAVIRUS INFECTION; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HOST; HUMAN; IMMUNOHISTOCHEMISTRY; MESSENGER RNA SYNTHESIS; MOLECULAR BIOLOGY; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA EDITING; RNA VIRUS; SEQUENCE HOMOLOGY; SERODIAGNOSIS; VIRULENCE; VIRUS ASSEMBLY; VIRUS MORPHOLOGY; VIRUS REPLICATION; MOLECULAR GENETICS; PHYLOGENY; VIRUS GENOME;

BUNYAVIRIDAE; HANTAVIRUS; RODENTIA;

GENOME, VIRAL; GLYCOPROTEINS; HANTAVIRUS; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; RNA REPLICASE; RNA, VIRAL; VIRULENCE;

EID: 79953206611     PISSN: 00652164     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-387022-3.00006-9     Document Type: Chapter

References (274)

1. Alfadhli A., Love Z., Arvidson B., Seeds J., Willey J., Barklis E. Hantavirus nucleocapsid protein oligomerization. J. Virol. 2001, 75:2019-2023.
2. Alfadhli A., Steel E., Finlay L., Bachinger H.P., Barklis E. Hantavirus nucleocapsid protein coiled-coil domains. J. Biol. Chem. 2002, 277:27103-27108.
3. Alff P.J., Gavrilovskaya I.N., Gorbunova E., Endriss K., Chong Y., Geimonen E., Sen N., Reich N.C., Mackow E.R. The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. J. Virol. 2006, 80:9676-9686.
4. Alff P.J., Sen N., Gorbunova E., Gavrilovskaya I.N., Mackow E.R. The NY-1 hantavirus Gn cytoplasmic tail coprecipitates TRAF3 and inhibits cellular interferon responses by disrupting TBK1-TRAF3 complex formation. J. Virol. 2008, 82:9115-9122.
5. Andersson A.M., Melin L., Bean A., Pettersson R.F. A retention signal necessary and sufficient for Golgi localization maps to the cytoplasmic tail of a Bunyaviridae (Uukuniemi virus) membrane glycoprotein. J. Virol. 1997, 71:4717-4727.
6. Antic D., Kang C.Y., Spik K., Schmaljohn C., Vapalahti O., Vaheri A. Comparison of the deduced gene products of the L, M and S genome segments of hantaviruses. Virus Res. 1992, 24:35-46.
7. Antic D., Wright K.E., Kang C.Y. Maturation of Hantaan virus glycoproteins G1 and G2. Virology 1992, 189:324-328.
8. Aquino V.H., Moreli M.L., Moraes Figueiredo L.T. Analysis of oropouche virus L protein amino acid sequence showed the presence of an additional conserved region that could harbour an important role for the polymerase activity. Arch. Virol. 2003, 148:19-28.
9. Arai S., Song J.W., Sumibcay L., Bennett S.N., Nerurkar V.R., Parmenter C., Cook J.A., Yates T.L., Yanagihara R. Hantavirus in northern short-tailed shrew, United States. Emerg. Infect. Dis. 2007, 13:1420-1423.
10. Arikawa J., Schmaljohn A.L., Dalrymple J.M., Schmaljohn C.S. Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies. J. Gen. Virol. 1989, 70(Pt. 3):615-624.
11. Arnold J.J., Cameron C.E. Poliovirus RNA-dependent RNA polymerase (3Dpol): Pre-steady-state kinetic analysis of ribonucleotide incorporation in the presence of Mg2+. Biochemistry 2004, 43:5126-5137.
12. Arnold J.J., Ghosh S.K., Cameron C.E. Poliovirus RNA-dependent RNA polymerase (3D(pol)). Divalent cation modulation of primer, template, and nucleotide selection. J. Biol. Chem. 1999, 274:37060-37069.
13. Avsic-Zupanc T., Toney A., Anderson K., Chu Y.K., Schmaljohn C. Genetic and antigenic properties of Dobrava virus: A unique member of the Hantavirus genus, family Bunyaviridae. J. Gen. Virol. 1995, 76(Pt. 11):2801-2808.
14. Avsic-Zupanc T., Nemirov K., Petrovec M., Trilar T., Poljak M., Vaheri A., Plyusnin A. Genetic analysis of wild-type Dobrava hantavirus in Slovenia: Co-existence of two distinct genetic lineages within the same natural focus. J. Gen. Virol. 2000, 81:1747-1755.
15. Barclay C.M., Rubinstein G. Hantavirus in Argentina. Nature 1997, 386:320.
16. Barr J.N., Fearns R. How RNA viruses maintain their genome integrity. J. Gen. Virol. 2010, 91:1373-1387.
17. Bayard V., Kitsutani P.T., Barria E.O., Ruedas L.A., Tinnin D.S., Munoz C., de Mosca I.B., Guerrero G., Kant R., Garcia A., Caceres L., Gracio F.G., et al. Outbreak of hantavirus pulmonary syndrome, Los Santos, Panama, 1999-2000. Emerg. Infect. Dis. 2004, 10:1635-1642.
18. Beckham C.J., Parker R. P bodies, stress granules, and viral life cycles. Cell Host Microbe 2008, 3:206-212.
19. Bharadwaj M., Lyons C.R., Wortman I.A., Hjelle B. Intramuscular inoculation of Sin Nombre hantavirus cDNAs induces cellular and humoral immune responses in BALB/c mice. Vaccine 1999, 17:2836-2843.
20. Bharadwaj M., Mirowsky K., Ye C., Botten J., Masten B., Yee J., Lyons C.R., Hjelle B. Genetic vaccines protect against Sin Nombre hantavirus challenge in the deer mouse (Peromyscus maniculatus). J. Gen. Virol. 2002, 83:1745-1751.
21. Bishop D.H., Gay M.E., Matsuoko Y. Nonviral heterogeneous sequences are present at the 5' ends of one species of snowshoe hare bunyavirus S complementary RNA. Nucleic Acids Res. 1983, 11:6409-6418.
22. Blakqori G., Kochs G., Haller O., Weber F. Functional L polymerase of La Crosse virus allows in vivo reconstitution of recombinant nucleocapsids. J. Gen. Virol. 2003, 84:1207-1214.
23. Bohlman M.C., Morzunov S.P., Meissner J., Taylor M.B., Ishibashi K., Rowe J., Levis S., Enria D., St.Jeor S.C. Analysis of hantavirus genetic diversity in Argentina: S segment-derived phylogeny. J. Virol. 2002, 76:3765-3773.
24. Borges A.A., Campos G.M., Moreli M.L., Souza R.L., Aquino V.H., Saggioro F.P., Figueiredo L.T. Hantavirus cardiopulmonary syndrome: Immune response and pathogenesis. Microbes Infect. 2006, 8:2324-2330.
25. Boroja M., Barrie J.R., Raymond G.S. Radiographic findings in 20 patients with Hantavirus pulmonary syndrome correlated with clinical outcome. AJR Am. J. Roentgenol. 2002, 178:159-163.
26. Bostik P., Winter J., Ksiazek T.G., Rollin P.E., Villinger F., Zaki S.R., Peters C.J., Ansari A.A. Sin nombre virus (SNV) Ig isotype antibody response during acute and convalescent phases of hantavirus pulmonary syndrome. Emerg. Infect. Dis. 2000, 6:184-187.
27. Botten J., Mirowsky K., Ye C., Gottlieb K., Saavedra M., Ponce L., Hjelle B. Shedding and intracage transmission of Sin Nombre hantavirus in the deer mouse (Peromyscus maniculatus) model. J. Virol. 2002, 76:7587-7594.
28. Bouloy M., Plotch S.J., Krug R.M. Globin mRNAs are primers for the transcription of influenza viral RNA in vitro. Proc. Natl. Acad. Sci. USA 1978, 75:4886-4890.
29. Bressanelli S., Tomei L., Rey F.A., De Francesco R. Structural analysis of the hepatitis C virus RNA polymerase in complex with ribonucleotides. J. Virol. 2002, 76:3482-3492.
30. Bridgen A., Elliott R.M. Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs. Proc. Natl. Acad. Sci. USA 1996, 93:15400-15404.
31. Bruenn J.A. A structural and primary sequence comparison of the viral RNA-dependent RNA polymerases. Nucleic Acids Res. 2003, 31:1821-1829.
32. Butcher S.J., Grimes J.M., Makeyev E.V., Bamford D.H., Stuart D.I. A mechanism for initiating RNA-dependent RNA polymerization. Nature 2001, 410:235-240.
33. Calisher C.H., Peters C.J., Douglass R.J., Kuenzi A.J. Hantaviral infections of rodents: Possible scenarios. Arch. Virol. 2009, 154:1195-1197.
34. Cevik B., Smallwood S., Moyer S.A. The L-L oligomerization domain resides at the very N-terminus of the sendai virus L RNA polymerase protein. Virology 2003, 313:525-536.
35. Cevik B., Holmes D.E., Vrotsos E., Feller J.A., Smallwood S., Moyer S.A. The phosphoprotein (P) and L binding sites reside in the N-terminus of the L subunit of the measles virus RNA polymerase. Virology 2004, 327:297-306.
36. Chan Y.C., Wong T.W., Yap E.H. Haemorrhagic fever with renal syndrome: Clinical, virological and epidemiological perspectives. Ann. Acad. Med. Singapore 1987, 16:696-701.
37. Chapman L.E., Mertz G.J., Peters C.J., Jolson H.M., Khan A.S., Ksiazek T.G., Koster F.T., Baum K.F., Rollin P.E., Pavia A.T., Holman R.C., Christenson J.C., et al. Intravenous ribavirin for hantavirus pulmonary syndrome: Safety and tolerance during 1 year of open-label experience. Ribavirin Study Group. Antivir. Ther. 1999, 4:211-219.
38. Chen L.B., Yang W.S. Abnormalities of T cell immunoregulation in hemorrhagic fever with renal syndrome. J. Infect. Dis. 1990, 161:1016-1019.
39. Childs J.E., Glass G.E., Korch G.W., LeDuc J.W. Effects of hantaviral infection on survival, growth and fertility in wild rat (Rattus norvegicus) populations of Baltimore, Maryland. J. Wildl. Dis. 1989, 25:469-476.
40. Chizhikov V.E., Spiropoulou C.F., Morzunov S.P., Monroe M.C., Peters C.J., Nichol S.T. Complete genetic characterization and analysis of isolation of Sin Nombre virus. J. Virol. 1995, 69:8132-8136.
41. Cho H.W., Howard C.R. Antibody responses in humans to an inactivated hantavirus vaccine (Hantavax). Vaccine 1999, 17:2569-2575.
42. Cho H.W., Howard C.R., Lee H.W. Review of an inactivated vaccine against hantaviruses. Intervirology 2002, 45:328-333.
43. Choi Y., Ahn C.J., Seong K.M., Jung M.Y., Ahn B.Y. Inactivated Hantaan virus vaccine derived from suspension culture of Vero cells. Vaccine 2003, 21:1867-1873.
44. Chu Y.K., Jennings G.B., Schmaljohn C.S. A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus. J. Virol. 1995, 69:6417-6423.
45. Chu Y.K., Milligan B., Owen R.D., Goodin D.G., Jonsson C.B. Phylogenetic and geographical relationships of hantavirus strains in eastern and western Paraguay. Am. J. Trop. Med. Hyg. 2006, 75:1127-1134.
46. Clement J., Lameire N., Keyaerts E., Maes P., Van Ranst M. Hantavirus infections in Europe. Lancet Infect. Dis. 2003, 3:752-753. discussion 753-754.
47. Copper P.D., Steiner-Pryor A., Scotti P.D., Delong D. On the nature of poliovirus genetic recombinants. J. Gen. Virol. 1974, 23:41-49.
48. Crotty S., Andino R. Implications of high RNA virus mutation rates: Lethal mutagenesis and the antiviral drug ribavirin. Microbes Infect. 2002, 4:1301-1307.
49. Dahlberg J.E., Obijeski J.F., Korb J. Electron microscopy of the segmented RNA genome of La Crosse virus: Absence of circular molecules. J. Virol. 1977, 22:203-209.
50. Dargeviciute A., Brus Sjolander K., Sasnauskas K., Kruger D.H., Meisel H., Ulrich R., Lundkvist A. Yeast-expressed Puumala hantavirus nucleocapsid protein induces protection in a bank vole model. Vaccine 2002, 20:3523-3531.
51. de Carvalho Nicacio C., Sallberg M., Hultgren C., Lundkvist A. T-helper and humoral responses to Puumala hantavirus nucleocapsid protein: Identification of T-helper epitopes in a mouse model. J. Gen. Virol. 2001, 82:129-138.
52. de Haan P., Kormelink R., de Oliveira Resende R., van Poelwijk F., Peters D., Goldbach R. Tomato spotted wilt virus L RNA encodes a putative RNA polymerase. J. Gen. Virol. 1991, 72(Pt. 9):2207-2216.
53. Deyde V.M., Rizvanov A.A., Chase J., Otteson E.W., St.Jeor S.C. Interactions and trafficking of Andes and Sin Nombre Hantavirus glycoproteins G1 and G2. Virology 2005, 331:307-315.
54. Doublie S., Ellenberger T. The mechanism of action of T7 DNA polymerase. Curr. Opin. Struct. Biol. 1998, 8:704-712.
55. Drake J.W. The distribution of rates of spontaneous mutation over viruses, prokaryotes, and eukaryotes. Ann. NY Acad. Sci. 1999, 870:100-107.
56. Dunn E.F., Pritlove D.C., Jin H., Elliott R.M. Transcription of a recombinant bunyavirus RNA template by transiently expressed bunyavirus proteins. Virology 1995, 211:133-143.
57. Ebihara H., Yoshimatsu K., Ogino M., Araki K., Ami Y., Kariwa H., Takashima I., Li D., Arikawa J. Pathogenicity of Hantaan virus in newborn mice: Genetic reassortant study demonstrating that a single amino acid change in glycoprotein G1 is related to virulence. J. Virol. 2000, 74:9245-9255.
58. Elgh F., Lundkvist A., Alexeyev O.A., Wadell G., Juto P. A major antigenic domain for the human humoral response to Puumala virus nucleocapsid protein is located at the amino-terminus. J. Virol. Methods 1996, 59:161-172.
59. Elgh F., Lundkvist A., Alexeyev O.A., Stenlund H., Avsic-Zupanc T., Hjelle B., Lee H.W., Smith K.J., Vainionpaa R., Wiger D., Wadell G., Juto P. Serological diagnosis of hantavirus infections by an enzyme-linked immunosorbent assay based on detection of immunoglobulin G and M responses to recombinant nucleocapsid proteins of five viral serotypes. J. Clin. Microbiol. 1997, 35:1122-1130.
60. Elliott L.H., Kiley M.P., McCormick J.B. Hantaan virus: Identification of virion proteins. J. Gen. Virol. 1984, 65(Pt. 8):1285-1293.
61. Eshita Y., Ericson B., Romanowski V., Bishop D.H. Analyses of the mRNA transcription processes of snowshoe hare bunyavirus S and M RNA species. J. Virol. 1985, 55:681-689.
62. Estrada D.F., Boudreaux D.M., Zhong D., St.Jeor S.C., De Guzman R.N. The hantavirus glycoprotein G1 tail contains dual CCHC-type classical zinc fingers. J. Biol. Chem. 2009, 284:8654-8660.
63. Fabbri M., Maslow M.J. Hantavirus pulmonary syndrome in the United States. Curr. Infect. Dis. Rep. 2001, 3:258-265.
64. Fazakerley J.K., Ross A.M. Computer analysis suggests a role for signal sequences in processing polyproteins of enveloped RNA viruses and as a mechanism of viral fusion. Virus Genes 1989, 2:223-239.
65. Flick R., Pettersson R.F. Reverse genetics system for Uukuniemi virus (Bunyaviridae): RNA polymerase I-catalyzed expression of chimeric viral RNAs. J. Virol. 2001, 75:1643-1655.
66. Flick K., Hooper J.W., Schmaljohn C.S., Pettersson R.F., Feldmann H., Flick R. Rescue of Hantaan virus minigenomes. Virology 2003, 306:219-224.
67. Fulhorst C.F., Monroe M.C., Salas R.A., Duno G., Utrera A., Ksiazek T.G., Nichol S.T., de Manzione N.M., Tovar D., Tesh R.B. Isolation, characterization and geographic distribution of Cano Delgadito virus, a newly discovered South American hantavirus (family Bunyaviridae). Virus Res. 1997, 51:159-171.
68. Garcin D., Lezzi M., Dobbs M., Elliott R.M., Schmaljohn C., Kang C.Y., Kolakofsky D. The 5' ends of Hantaan virus (Bunyaviridae) RNAs suggest a prime-and-realign mechanism for the initiation of RNA synthesis. J. Virol. 1995, 69:5754-5762.
69. Gavrilovskaya I.N., Shepley M., Shaw R., Ginsberg M.H., Mackow E.R. beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc. Natl. Acad. Sci. USA 1998, 95:7074-7079.
70. Gavrilovskaya I.N., Brown E.J., Ginsberg M.H., Mackow E.R. Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins. J. Virol. 1999, 73:3951-3959.
71. Gavrilovskaya I.N., Peresleni T., Geimonen E., Mackow E.R. Pathogenic hantaviruses selectively inhibit beta3 integrin directed endothelial cell migration. Arch. Virol. 2002, 147:1913-1931.
72. Geimonen E., Fernandez I., Gavrilovskaya I.N., Mackow E.R. Tyrosine residues direct the ubiquitination and degradation of the NY-1 hantavirus G1 cytoplasmic tail. J. Virol. 2003, 77:10760-10868.
73. Geimonen E., LaMonica R., Springer K., Farooqui Y., Gavrilovskaya I.N., Mackow E.R. Hantavirus pulmonary syndrome-associated hantaviruses contain conserved and functional ITAM signaling elements. J. Virol. 2003, 77:1638-1643.
74. Geldmacher A., Schmaler M., Kruger D.H., Ulrich R. Yeast-expressed hantavirus Dobrava nucleocapsid protein induces a strong, long-lasting, and highly cross-reactive immune response in mice. Viral Immunol. 2004, 17:115-122.
75. Gerrard S.R., Nichol S.T. Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoprotein. J. Virol. 2002, 76:12200-12210.
76. Glass G.E., Childs J.E., Korch G.W., LeDuc J.W. Association of intraspecific wounding with hantaviral infection in wild rats (Rattus norvegicus). Epidemiol. Infect. 1988, 101:459-472.
77. Gohara D.W., Crotty S., Arnold J.J., Yoder J.D., Andino R., Cameron C.E. Poliovirus RNA-dependent RNA polymerase (3Dpol): Structural, biochemical, and biological analysis of conserved structural motifs A and B. J. Biol. Chem. 2000, 275:25523-25532.
78. Gohara D.W., Arnold J.J., Cameron C.E. Poliovirus RNA-dependent RNA polymerase (3Dpol): Kinetic, thermodynamic, and structural analysis of ribonucleotide selection. Biochemistry 2004, 43:5149-5158.
79. Goldsmith C.S., Elliott L.H., Peters C.J., Zaki S.R. Ultrastructural characteristics of Sin Nombre virus, causative agent of hantavirus pulmonary syndrome. Arch. Virol. 1995, 140:2107-2122.
80. Golovljova I., Vasilenko V., Prukk T., Brus Sjolander K., Plyusnin A., Lundkvist A. Puumala and Dobrava hantaviruses causing hemorrhagic fever with renal syndrome in Estonia. Eur. J. Clin. Microbiol. Infect. Dis. 2000, 19:968-969.
81. Gott P., Stohwasser R., Schnitzler P., Darai G., Bautz E.K. RNA binding of recombinant nucleocapsid proteins of hantaviruses. Virology 1993, 194:332-337.
82. Gott P., Zoller L., Darai G., Bautz E.K. A major antigenic domain of hantaviruses is located on the aminoproximal site of the viral nucleocapsid protein. Virus Genes 1997, 14:31-40.
83. Groen J., Gerding M., Jordans J.G., Clement J.P., Osterhaus A.D. Class and subclass distribution of Hantavirus-specific serum antibodies at different times after the onset of nephropathia epidemica. J. Med. Virol. 1994, 43:39-43.
84. Handke W., Oelschlegel R., Franke R., Wiedemann L., Kruger D.H., Rang A. Generation and characterisation of genetic reassortants between Puumala and Prospect Hill hantavirus in vitro. J. Gen. Virol. 2010, 91:2351-2359.
85. Hansen J.L., Long A.M., Schultz S.C. Structure of the RNA-dependent RNA polymerase of poliovirus. Structure 1997, 5:1109-1122.
86. Hart C.A., Bennett M. Hantavirus infections: Epidemiology and pathogenesis. Microbes Infect. 1999, 1:1229-1237.
87. Hass M., Lelke M., Busch C., Becker-Ziaja B., Gunther S. Mutational evidence for a structural model of the Lassa virus RNA polymerase domain and identification of two residues, Gly1394 and Asp1395, that are critical for transcription but not replication of the genome. J. Virol. 2008, 82:10207-10217.
88. Hayasaka D., Maeda K., Ennis F.A., Terajima M. Increased permeability of human endothelial cell line EA.hy926 induced by hantavirus-specific cytotoxic T lymphocytes. Virus Res. 2007, 123:120-127.
89. Henderson W.W., Monroe M.C., St.Jeor S.C., Thayer W.P., Rowe J.E., Peters C.J., Nichol S.T. Naturally occurring Sin Nombre virus genetic reassortants. Virology 1995, 214:602-610.
90. Hepojoki J., Strandin T., Vaheri A., Lankinen H. Interactions and oligomerization of hantavirus glycoproteins. J. Virol. 2010, 84:227-242.
91. Hepojoki J.M., Strandin T., Wang H., Vapalahti O., Vaheri A., Lankinen H. The cytoplasmic tails of hantavirus glycoproteins interact with the nucleocapsid protein. J. Gen. Virol. 2010, 91:2341-2350.
92. Hewlett M.J., Pettersson R.F., Baltimore D. Circular forms of Uukuniemi virion RNA: An electron microscopic study. J. Virol. 1977, 21:1085-1093.
93. Hinson E.R., Shone S.M., Zink M.C., Glass G.E., Klein S.L. Wounding: The primary mode of Seoul virus transmission among male Norway rats. Am. J. Trop. Med. Hyg. 2004, 70:310-317.
94. Hjelle B., Chavez-Giles F., Torrez-Martinez N., Yamada T., Sarisky J., Ascher M., Jenison S. Dominant glycoprotein epitope of four corners hantavirus is conserved across a wide geographical area. J. Gen. Virol. 1994, 75(Pt. 11):2881-2888.
95. Hjelle B., Torrez-Martinez N., Koster F.T. Hantavirus pulmonary syndrome-related virus from Bolivia. Lancet 1996, 347:57.
96. Hjelle B., Jenison S., Torrez-Martinez N., Herring B., Quan S., Polito A., Pichuantes S., Yamada T., Morris C., Elgh F., Lee H.W., Artsob H., et al. Rapid and specific detection of Sin Nombre virus antibodies in patients with hantavirus pulmonary syndrome by a strip immunoblot assay suitable for field diagnosis. J. Clin. Microbiol. 1997, 35:600-608.
97. Hooper J., Schmaljohn C.S. Hantavirus. The Springer Index of Viruses 2001, 150-156. Springer-Verlag, Berlin Heidelberg New York. C.A. Tidona, G. Darai (Eds.).
98. Hooper J.W., Kamrud K.I., Elgh F., Custer D., Schmaljohn C.S. DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against seoul virus infection. Virology 1999, 255:269-278.
99. Huang H., Chopra R., Verdine G.L., Harrison S.C. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: Implications for drug resistance. Science 1998, 282:1669-1675.
100. Huggins J.W., Kim G.R., Brand O.M., McKee K.T. Ribavirin therapy for Hantaan virus infection in suckling mice. J. Infect. Dis. 1986, 153:489-497.
101. Huggins J.W., Hsiang C.M., Cosgriff T.M., Guang M.Y., Smith J.I., Wu Z.O., LeDuc J.W., Zheng Z.M., Meegan J.M., Wang Q.N., et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J. Infect. Dis. 1991, 164:1119-1127.
102. Huiskonen J.T., Overby A.K., Weber F., Grunewald K. Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: Evidence for GN-GC glycoprotein heterodimers. J. Virol. 2009, 83:3762-3769.
103. Huiskonen J.T., Hepojoki J., Laurinmaki P., Vaheri A., Lankinen H., Butcher S.J., Grunewald K. Electron cryotomography of Tula hantavirus suggests a unique assembly paradigm for enveloped viruses. J. Virol. 2010, 84:4889-4897.
104. Hutchinson K.L., Peters C.J., Nichol S.T. Sin Nombre virus mRNA synthesis. Virology 1996, 224:139-149.
105. Hutchinson K.L., Rollin P.E., Shieh W.J., Zaki S., Greer P.W., Peters C.J. Transmission of Black Creek Canal virus between cotton rats. J. Med. Virol. 2000, 60:70-76.
106. Ikegami T., Peters C.J., Makino S. Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system. J. Virol. 2005, 79:5606-5615.
107. Isegawa Y., Tanishita O., Ueda S., Yamanishi K. Association of serine in position 1124 of Hantaan virus glycoprotein with virulence in mice. J. Gen. Virol. 1994, 75(Pt. 11):3273-3278.
108. Jablonski S.A., Morrow C.D. Mutation of the aspartic acid residues of the GDD sequence motif of poliovirus RNA-dependent RNA polymerase results in enzymes with altered metal ion requirements for activity. J. Virol. 1995, 69:1532-1539.
109. Jackson A.P., Charleston M.A. A cophylogenetic perspective of RNA-virus evolution. Mol. Biol. Evol. 2004, 21:45-57.
110. Jakab F., Horvath G., Ferenczi E., Sebok J., Varecza Z., Szucs G. Detection of Dobrava hantaviruses in Apodemus agrarius mice in the Transdanubian region of Hungary. Virus Res. 2007, 128:149-152.
111. Jenison S., Yamada T., Morris C., Anderson B., Torrez-Martinez N., Keller N., Hjelle B. Characterization of human antibody responses to four corners hantavirus infections among patients with hantavirus pulmonary syndrome. J. Virol. 1994, 68:3000-3006.
112. Jiang W., Hou Y., Inouye M. CspA, the major cold-shock protein of Escherichia coli, is an RNA chaperone. J. Biol. Chem. 1997, 272:196-202.
113. Jin H., Elliott R.M. Characterization of Bunyamwera virus S RNA that is transcribed and replicated by the L protein expressed from recombinant vaccinia virus. J. Virol. 1993, 67:1396-1404.
114. Jin M., Park J., Lee S., Park B., Shin J., Song K.J., Ahn T.I., Hwang S.Y., Ahn B.Y., Ahn K. Hantaan virus enters cells by clathrin-dependent receptor-mediated endocytosis. Virology 2002, 294:60-69.
115. Johnson A.M., Bowen M.D., Ksiazek T.G., Williams R.J., Bryan R.T., Mills J.N., Peters C.J., Nichol S.T. Laguna Negra virus associated with HPS in western Paraguay and Bolivia. Virology 1997, 238:115-127.
116. Jones K.E., Patel N.G., Levy M.A., Storeygard A., Balk D., Gittleman J.L., Daszak P. Global trends in emerging infectious diseases. Nature 2008, 451:990-993.
117. Jonsson C.B., Gallegos J., Ferro P., Severson W., Xu X., Schmaljohn C.S. Purification and characterization of the Sin Nombre virus nucleocapsid protein expressed in Escherichia coli. Protein Expr. Purif. 2001, 23:134-141.
118. Jonsson C.B., Figueiredo L.T., Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease. Clin. Microbiol. Rev. 2010, 23:412-441.
119. Joyce C.M., Steitz T.A. Polymerase structures and function: Variations on a theme?. J. Bacteriol. 1995, 177:6321-6329.
120. Kallio E.R., Poikonen A., Vaheri A., Vapalahti O., Henttonen H., Koskela E., Mappes T. Maternal antibodies postpone hantavirus infection and enhance individual breeding success. Proc. Biol. Sci. 2006, 273:2771-2776.
121. Kamer G., Argos P. Primary structural comparison of RNA-dependent polymerases from plant, animal and bacterial viruses. Nucleic Acids Res. 1984, 12:7269-7282.
122. Kanerva M., Mustonen J., Vaheri A. Pathogenesis of puumala and other hantavirus infections. Rev. Med. Virol. 1998, 8:67-86.
123. Kang H.J., Bennett S.N., Dizney L., Sumibcay L., Arai S., Ruedas L.A., Song J.W., Yanagihara R. Host switch during evolution of a genetically distinct hantavirus in the American shrew mole (Neurotrichus gibbsii). Virology 2009, 388:8-14.
124. Kang H.J., Bennett S.N., Sumibcay L., Arai S., Hope A.G., Mocz G., Song J.W., Cook J.A., Yanagihara R. Evolutionary insights from a genetically divergent hantavirus harbored by the European common mole (Talpa europaea). PLoS ONE 2009, 4:e6149.
125. Kariwa H., Fujiki M., Yoshimatsu K., Arikawa J., Takashima I., Hashimoto N. Urine-associated horizontal transmission of Seoul virus among rats. Arch. Virol. 1998, 143:365-374.
126. Kaukinen P., Koistinen V., Vapalahti O., Vaheri A., Plyusnin A. Interaction between molecules of hantavirus nucleocapsid protein. J. Gen. Virol. 2001, 82:1845-1853.
127. Kaukinen P., Vaheri A., Plyusnin A. Mapping of the regions involved in homotypic interactions of Tula hantavirus N protein. J. Virol. 2003, 77:10910-10916.
128. Kaukinen P., Kumar V., Tulimaki K., Engelhardt P., Vaheri A., Plyusnin A. Oligomerization of Hantavirus N protein: C-terminal alpha-helices interact to form a shared hydrophobic space. J. Virol. 2004, 78:13669-13677.
129. Khaiboullina S.F., St Jeor S.C. Hantavirus immunology. Viral Immunol. 2002, 15:609-625.
130. Kilpatrick E.D., Terajima M., Koster F.T., Catalina M.D., Cruz J., Ennis F.A. Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J. Immunol. 2004, 172:3297-3304.
131. Kim Y.S., Ahn C., Han J.S., Kim S., Lee J.S., Lee P.W. Hemorrhagic fever with renal syndrome caused by the Seoul virus. Nephron 1995, 71:419-427.
132. Klempa B., Stanko M., Labuda M., Ulrich R., Meisel H., Kruger D.H. Central European Dobrava Hantavirus isolate from a striped field mouse (Apodemus agrarius). J. Clin. Microbiol. 2005, 43:2756-2763.
133. Klempa B., Tkachenko E.A., Dzagurova T.K., Yunicheva Y.V., Morozov V.G., Okulova N.M., Slyusareva G.P., Smirnov A., Kruger D.H. Hemorrhagic fever with renal syndrome caused by 2 lineages of Dobrava hantavirus, Russia. Emerg. Infect. Dis. 2008, 14:617-625.
134. Klingstrom J., Falk K.I., Lundkvist A. Delayed viremia and antibody responses in Puumala hantavirus challenged passively immunized cynomolgus macaques. Arch. Virol. 2005, 150:79-92.
135. Klingstrom J., Hardestam J., Lundkvist A. Dobrava, but not Saaremaa, hantavirus is lethal and induces nitric oxide production in suckling mice. Microbes Infect. 2006, 8:728-737.
136. Klingstrom J., Hardestam J., Stoltz M., Zuber B., Lundkvist A., Linder S., Ahlm C. Loss of cell membrane integrity in puumala hantavirus-infected patients correlates with levels of epithelial cell apoptosis and perforin. J. Virol. 2006, 80:8279-8282.
137. Kohl A., Hart T.J., Noonan C., Royall E., Roberts L.O., Elliott R.M. A bunyamwera virus minireplicon system in mosquito cells. J. Virol. 2004, 78:5679-5685.
138. Kohlstaedt L.A., Wang J., Friedman J.M., Rice P.A., Steitz T.A. Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 1992, 256:1783-1790.
139. Kramski M., Achazi K., Klempa B., Kruger D.H. Nephropathia epidemica with a 6-week incubation period after occupational exposure to Puumala hantavirus. J. Clin. Virol. 2009, 44:99-101.
140. Krug R.M. Priming of influenza viral RNA transcription by capped heterologous RNAs. Curr. Top. Microbiol. Immunol. 1981, 93:125-149.
141. Krug R.M., Broni B.A., Bouloy M. Are the 5' ends of influenza viral mRNAs synthesized in vivo donated by host mRNAs?. Cell 1979, 18:329-334.
142. Kuismanen E., Hedman K., Saraste J., Pettersson R.F. Uukuniemi virus maturation: Accumulation of virus particles and viral antigens in the Golgi complex. Mol. Cell. Biol. 1982, 2:1444-1458.
143. Kukkonen S.K., Vaheri A., Plyusnin A. Completion of the Tula hantavirus genome sequence: Properties of the L segment and heterogeneity found in the 3' termini of S and L genome RNAs. J. Gen. Virol. 1998, 79(Pt. 11):2615-2622.
144. Kukkonen S.K., Vaheri A., Plyusnin A. Tula hantavirus L protein is a 250kDa perinuclear membrane-associated protein. J. Gen. Virol. 2004, 85:1181-1189.
145. Lappin D.F., Nakitare G.W., Palfreyman J.W., Elliott R.M. Localization of Bunyamwera bunyavirus G1 glycoprotein to the Golgi requires association with G2 but not with NSm. J. Gen. Virol. 1994, 75(Pt. 12):3441-3451.
146. Larson R.S., Brown D.C., Ye C., Hjelle B. Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor. J. Virol. 2005, 79:7319-7326.
147. Lee H.W., French G.R., Lee P.W., Baek L.J., Tsuchiya K., Foulke R.S. Observations on natural and laboratory infection of rodents with the etiologic agent of Korean hemorrhagic fever. Am. J. Trop. Med. Hyg. 1981, 30:477-482.
148. Lee H.W., Lee P.W., Baek L.J., Song C.K., Seong I.W. Intraspecific transmission of Hantaan virus, etiologic agent of Korean hemorrhagic fever, in the rodent Apodemus agrarius. Am. J. Trop. Med. Hyg. 1981, 30:1106-1112.
149. Lee B.H., Yoshimatsu K., Maeda A., Ochiai K., Morimatsu M., Araki K., Ogino M., Morikawa S., Arikawa J. Association of the nucleocapsid protein of the Seoul and Hantaan hantaviruses with small ubiquitin-like modifier-1-related molecules. Virus Res. 2003, 98:83-91.
150. Lesburg C.A., Cable M.B., Ferrari E., Hong Z., Mannarino A.F., Weber P.C. Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site. Nat. Struct. Biol. 1999, 6:937-943.
151. Li D., Schmaljohn A.L., Anderson K., Schmaljohn C.S. Complete nucleotide sequences of the M and S segments of two hantavirus isolates from California: Evidence for reassortment in nature among viruses related to hantavirus pulmonary syndrome. Virology 1995, 206:973-983.
152. Li Z., Bai X., Bian H. Serologic diagnosis of Hantaan virus infection based on a peptide antigen. Clin. Chem. 2002, 48:645-647.
153. Linderholm M., Ahlm C., Settergren B., Waage A., Tarnvik A. Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J. Infect. Dis. 1996, 173:38-43.
154. Lober C., Anheier B., Lindow S., Klenk H.D., Feldmann H. The Hantaan virus glycoprotein precursor is cleaved at the conserved pentapeptide WAASA. Virology 2001, 289:224-229.
155. Lopez N., Muller R., Prehaud C., Bouloy M. The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA molecules. J. Virol. 1995, 69:3972-3979.
156. Lyubsky S., Gavrilovskaya I., Luft B., Mackow E. Histopathology of Peromyscus leucopus naturally infected with pathogenic NY-1 hantaviruses: Pathologic markers of HPS viral infection in mice. Lab. Invest. 1996, 74:627-633.
157. Mackow E.R., Gavrilovskaya I.N. Cellular receptors and hantavirus pathogenesis. Curr. Top. Microbiol. Immunol. 2001, 256:91-115.
158. Markotic A., Hensley L., Daddario K., Spik K., Anderson K., Schmaljohn C. Pathogenic hantaviruses elicit different immunoreactions in THP-1 cells and primary monocytes and induce differentiation of human monocytes to dendritic-like cells. Coll. Antropol. 2007, 31:1159-1167.
159. Martin M.L., Lindsey-Regnery H., Sasso D.R., McCormick J.B., Palmer E. Distinction between Bunyaviridae genera by surface structure and comparison with Hantaan virus using negative stain electron microscopy. Arch. Virol. 1985, 86:17-28.
160. Matsuoka Y., Chen S.Y., Compans R.W. A signal for Golgi retention in the bunyavirus G1 glycoprotein. J. Biol. Chem. 1994, 269:22565-22573.
161. McCaughey C., Hart C.A. Hantaviruses. J. Med. Microbiol. 2000, 49:587-599.
162. McClain D.J., Summers P.L., Harrison S.A., Schmaljohn A.L., Schmaljohn C.S. Clinical evaluation of a vaccinia-vectored Hantaan virus vaccine. J. Med. Virol. 2000, 60:77-85.
163. Medina R.A., Mirowsky-Garcia K., Hutt J., Hjelle B. Ribavirin, human convalescent plasma and anti-beta3 integrin antibody inhibit infection by Sin Nombre virus in the deer mouse model. J. Gen. Virol. 2007, 88:493-505.
164. Mertz G.J., Miedzinski L., Goade D., Pavia A.T., Hjelle B., Hansbarger C.O., Levy H., Koster F.T., Baum K., Lindemulder A., Wang W., Riser L., et al. Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin. Infect. Dis. 2004, 39:1307-1313.
165. Meyer B.J., Schmaljohn C. Accumulation of terminally deleted RNAs may play a role in Seoul virus persistence. J. Virol. 2000, 74:1321-1331.
166. Mills K.H. Regulatory T cells: Friend or foe in immunity to infection?. Nat. Rev. Immunol. 2004, 4:841-855.
167. Mir M.A. Hantaviruses. Clin. Lab. Med. 2010, 30:67-91.
168. Mir M.A., Panganiban A.T. Trimeric hantavirus nucleocapsid protein binds specifically to the viral RNA panhandle. J. Virol. 2004, 78:8281-8288.
169. Mir M.A., Panganiban A.T. The hantavirus nucleocapsid protein recognizes specific features of the viral RNA panhandle and is altered in conformation upon RNA binding. J. Virol. 2005, 79:1824-1835.
170. Mir M.A., Panganiban A.T. The triplet repeats of the Sin Nombre hantavirus 5' UTR are sufficient in cis for nucleocapsid-mediated translation initiation. J. Virol. 2010, 84:8937-8944.
171. Mir M.A., Brown B., Hjelle B., Duran W.A., Panganiban A.T. Hantavirus N protein exhibits genus-specific recognition of the viral RNA panhandle. J. Virol. 2006, 80:11283-11292.
172. Mir M.A., Panganiban A.T. A protein that replaces the entire cellular eIF4F complex. EMBO J. 2008, 27:3129-3139.
173. Mir M.A., Duran W.A., Hjelle B.L., Ye C., Panganiban A.T. Storage of cellular 5' mRNA caps in P bodies for viral cap-snatching. Proc. Natl. Acad. Sci. USA 2008, 105:19294-19299.
174. Mir M.A., Sheema S., Haseeb A., Haque A. Hantavirus nucleocapsid protein has distinct m7G cap- and RNA-binding sites. J. Biol. Chem. 2010, 285:11357-11368.
175. Moreli M.L., Sousa R.L., Figueiredo L.T. Detection of Brazilian hantavirus by reverse transcription polymerase chain reaction amplification of N gene in patients with hantavirus cardiopulmonary syndrome. Mem. Inst. Oswaldo Cruz 2004, 99:633-638.
176. Morens D.M., Folkers G.K., Fauci A.S. The challenge of emerging and re-emerging infectious diseases. Nature 2004, 430:242-249.
177. Mou D.L., Wang Y.P., Huang C.X., Li G.Y., Pan L., Yang W.S., Bai X.F. Cellular entry of Hantaan virus A9 strain: Specific interactions with beta3 integrins and a novel 70kDa protein. Biochem. Biophys. Res. Commun. 2006, 339:611-617.
178. Muller R., Poch O., Delarue M., Bishop D.H., Bouloy M. Rift Valley fever virus L segment: Correction of the sequence and possible functional role of newly identified regions conserved in RNA-dependent polymerases. J. Gen. Virol. 1994, 75(Pt. 6):1345-1352.
179. Muranyi W., Bahr U., Zeier M., van der Woude F.J. Hantavirus infection. J. Am. Soc. Nephrol. 2005, 16:3669-3679.
180. Nemirov K., Vapalahti O., Papa A., Plyusnina A., Lundkvist A., Antoniadis A., Vaheri A., Plyusnin A. Genetic characterization of new Dobrava hantavirus isolate from Greece. J. Med. Virol. 2003, 69:408-416.
181. Netski D., Thran B.H., St.Jeor S.C. Sin Nombre virus pathogenesis in Peromyscus maniculatus. J. Virol. 1999, 73:585-591.
182. Ng K.K., Arnold J.J., Cameron C.E. Structure-function relationships among RNA-dependent RNA polymerases. Curr. Top. Microbiol. Immunol. 2008, 320:137-156.
183. Nichol S.T., Spiropoulou C.F., Morzunov S., Rollin P.E., Ksiazek T.G., Feldmann H., Sanchez A., Childs J., Zaki S., Peters C.J. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 1993, 262:914-917.
184. Nolte K.B., Feddersen R.M., Foucar K., Zaki S.R., Koster F.T., Madar D., Merlin T.L., McFeeley P.J., Umland E.T., Zumwalt R.E. Hantavirus pulmonary syndrome in the United States: A pathological description of a disease caused by a new agent. Hum. Pathol. 1995, 26:110-120.
185. O'Reilly E.K., Kao C.C. Analysis of RNA-dependent RNA polymerase structure and function as guided by known polymerase structures and computer predictions of secondary structure. Virology 1998, 252:287-303.
186. Obijeski J.F., Murphy F.A. Bunyaviridae: Recent biochemical developments. J. Gen. Virol. 1977, 37:1-14.
187. Obijeski J.F., Bishop D.H., Palmer E.L., Murphy F.A. Segmented genome and nucleocapsid of La Crosse virus. J. Virol. 1976, 20:664-675.
188. Obijeski J.F., McCauley J., Skehel J.J. Nucleotide sequences at the terminal of La Crosse virus RNAs. Nucleic Acids Res. 1980, 8:2431-2438.
189. Osborne J.C., Elliott R.M. RNA binding properties of bunyamwera virus nucleocapsid protein and selective binding to an element in the 5' terminus of the negative-sense S segment. J. Virol. 2000, 74:9946-9952.
190. Overby A.K., Pettersson R.F., Neve E.P. The glycoprotein cytoplasmic tail of Uukuniemi virus (Bunyaviridae) interacts with ribonucleoproteins and is critical for genome packaging. J. Virol. 2007, 81:3198-3205.
191. Overby A.K., Pettersson R.F., Grunewald K., Huiskonen J.T. Insights into bunyavirus architecture from electron cryotomography of Uukuniemi virus. Proc. Natl. Acad. Sci. USA 2008, 105:2375-2379.
192. Padula P.J., Edelstein A., Miguel S.D., Lopez N.M., Rossi C.M., Rabinovich R.D. Hantavirus pulmonary syndrome outbreak in Argentina: Molecular evidence for person-to-person transmission of Andes virus. Virology 1998, 241:323-330.
193. Padula P.J., Sanchez A.J., Edelstein A., Nichol S.T. Complete nucleotide sequence of the M RNA segment of Andes virus and analysis of the variability of the termini of the virus S, M and L RNA segments. J. Gen. Virol. 2002, 83:2117-2122.
194. Panganiban A.T., Mir M.A. Bunyavirus N: eIF4F surrogate and cap-guardian. Cell Cycle 2009, 8:1332-1337.
195. Patterson J.L., Holloway B., Kolakofsky D. La Crosse virions contain a primer-stimulated RNA polymerase and a methylated cap-dependent endonuclease. J. Virol. 1984, 52:215-222.
196. Pensiero M.N., Hay J. The Hantaan virus M-segment glycoproteins G1 and G2 can be expressed independently. J. Virol. 1992, 66:1907-1914.
197. Peters C.J., Simpson G.L., Levy H. Spectrum of hantavirus infection: Hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Annu. Rev. Med. 1999, 50:531-545.
198. Pettersson R.F., von Bonsdorff C.H. Ribonucleoproteins of Uukuniemi virus are circular. J. Virol. 1975, 15:386-392.
199. Pinschewer D.D., Perez M., de la Torre J.C. Role of the virus nucleoprotein in the regulation of lymphocytic choriomeningitis virus transcription and RNA replication. J. Virol. 2003, 77:3882-3887.
200. Plotch S.J., Bouloy M., Ulmanen I., Krug R.M. A unique cap(m7G pppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell 1981, 23:847-858.
201. Plyusnin A. Genetics of hantaviruses: Implications to taxonomy. Arch. Virol. 2002, 147:665-682.
202. Plyusnin A., Morzunov S.P. Virus evolution and genetic diversity of hantaviruses and their rodent hosts. Curr. Top. Microbiol. Immunol. 2001, 256:47-75.
203. Plyusnin A., Horling J., Kanerva M., Mustonen J., Cheng Y., Partanen J., Vapalahti O., Kukkonen S.K., Niemimaa J., Henttonen H., Niklasson B., Lundkvist A., et al. Puumala hantavirus genome in patients with nephropathia epidemica: Correlation of PCR positivity with HLA haplotype and link to viral sequences in local rodents. J. Clin. Microbiol. 1997, 35:1090-1096.
204. Plyusnin A., Kukkonen S.K., Plyusnina A., Vapalahti O., Vaheri A. Transfection-mediated generation of functionally competent Tula hantavirus with recombinant S RNA segment. EMBO J. 2002, 21:1497-1503.
205. Poch O., Sauvaget I., Delarue M., Tordo N. Identification of four conserved motifs among the RNA-dependent polymerase encoding elements. EMBO J. 1989, 8:3867-3874.
206. Raftery M.J., Kraus A.A., Ulrich R., Kruger D.H., Schonrich G. Hantavirus infection of dendritic cells. J. Virol. 2002, 76:10724-10733.
207. Raju R., Kolakofsky D. Unusual transcripts in La Crosse virus-infected cells and the site for nucleocapsid assembly. J. Virol. 1987, 61:667-672.
208. Raju R., Kolakofsky D. The ends of La Crosse virus genome and antigenome RNAs within nucleocapsids are base paired. J. Virol. 1989, 63:122-128.
209. Ramanathan H.N., Jonsson C.B. New and Old World hantaviruses differentially utilize host cytoskeletal components during their life cycles. Virology 2008, 374:138-150.
210. Ramanathan H.N., Chung D.H., Plane S.J., Sztul E., Chu Y.K., Guttieri M.C., McDowell M., Ali G., Jonsson C.B. Dynein-dependent transport of the hantaan virus nucleocapsid protein to the endoplasmic reticulum-Golgi intermediate compartment. J. Virol. 2007, 81:8634-8647.
211. Ramsden C., Melo F.L., Figueiredo L.M., Holmes E.C., Zanotto P.M. High rates of molecular evolution in hantaviruses. Mol. Biol. Evol. 2008, 25:1488-1492.
212. Ravkov E.V., Compans R.W. Hantavirus nucleocapsid protein is expressed as a membrane-associated protein in the perinuclear region. J. Virol. 2001, 75:1808-1815.
213. Ravkov E.V., Nichol S.T., Compans R.W. Polarized entry and release in epithelial cells of Black Creek Canal virus, a New World hantavirus. J. Virol. 1997, 71:1147-1154.
214. Ravkov E.V., Nichol S.T., Peters C.J., Compans R.W. Role of actin microfilaments in Black Creek Canal virus morphogenesis. J. Virol. 1998, 72:2865-2870.
215. Rizvanov A.A., van Geelen A.G., Morzunov S., Otteson E.W., Bohlman C., Pari G.S., St.Jeor S.C. Generation of a recombinant cytomegalovirus for expression of a hantavirus glycoprotein. J. Virol. 2003, 77:12203-12210.
216. Rodriguez L.L., Owens J.H., Peters C.J., Nichol S.T. Genetic reassortment among viruses causing hantavirus pulmonary syndrome. Virology 1998, 242:99-106.
217. Root J.J., Black W.C.t., Calisher C.H., Wilson K.R., Beaty B.J. Genetic relatedness of deer mice (Peromyscus maniculatus) infected with Sin Nombre virus. Vector Borne Zoonotic Dis. 2004, 4:149-157.
218. Rossier C., Patterson J., Kolakofsky D. La Crosse virus small genome mRNA is made in the cytoplasm. J. Virol. 1986, 58:647-650.
219. Rothwell P.J., Waksman G. Structure and mechanism of DNA polymerases. Adv. Protein Chem. 2005, 71:401-440.
220. Ruo S.L., Sanchez A., Elliott L.H., Brammer L.S., McCormick J.B., Fisher-Hoch S.P. Monoclonal antibodies to three strains of hantaviruses: Hantaan, R22, and Puumala. Arch. Virol. 1991, 119:1-11.
221. Rusnak J.M., Byrne W.R., Chung K.N., Gibbs P.H., Kim T.T., Boudreau E.F., Cosgriff T., Pittman P., Kim K.Y., Erlichman M.S., Rezvani D.F., Huggins J.W. Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea. Antiviral Res. 2009, 81:68-76.
222. Ruusala A., Persson R., Schmaljohn C.S., Pettersson R.F. Coexpression of the membrane glycoproteins G1 and G2 of Hantaan virus is required for targeting to the Golgi complex. Virology 1992, 186:53-64.
223. Salonen A., Ahola T., Kaariainen L. Viral RNA replication in association with cellular membranes. Curr. Top. Microbiol. Immunol. 2005, 285:139-173.
224. Sanchez A.B., de la Torre J.C. Genetic and biochemical evidence for an oligomeric structure of the functional L polymerase of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 2005, 79:7262-7268.
225. Schmaljohn C., Hjelle B. Hantaviruses: A global disease problem. Emerg. Infect. Dis. 1997, 3:95-104.
226. Schmaljohn C.S., Nichol S.T. Bunyaviridae. Fields Virology 2007, 1741-1789. Lippincott Williams & Wilkins, Philadelphia. D.M. Knipe, P.M. Howley (Eds.).
227. Schmaljohn C.S., Hasty S.E., Dalrymple J.M., LeDuc J.W., Lee H.W., von Bonsdorff C.H., Brummer-Korvenkontio M., Vaheri A., Tsai T.F., Regnery H.L., et al. Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome. Science 1985, 227:1041-1044.
228. Schmaljohn C.S., Jennings G.B., Hay J., Dalrymple J.M. Coding strategy of the S genome segment of Hantaan virus. Virology 1986, 155:633-643.
229. Schmaljohn C.S., Schmaljohn A.L., Dalrymple J.M. Hantaan virus M RNA: Coding strategy, nucleotide sequence, and gene order. Virology 1987, 157:31-39.
230. Schmaljohn C.S., Chu Y.K., Schmaljohn A.L., Dalrymple J.M. Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. J. Virol. 1990, 64:3162-3170.
231. Schonrich G., Rang A., Lutteke N., Raftery M.J., Charbonnel N., Ulrich R.G. Hantavirus-induced immunity in rodent reservoirs and humans. Immunol. Rev. 2008, 225:163-189.
232. Sen N., Sen A., Mackow E.R. Degrons at the C terminus of the pathogenic but not the nonpathogenic hantavirus G1 tail direct proteasomal degradation. J. Virol. 2007, 81:4323-4330.
233. Severson W., Partin L., Schmaljohn C.S., Jonsson C.B. Characterization of the Hantaan nucleocapsid protein-ribonucleic acid interaction. J. Biol. Chem. 1999, 274:33732-33739.
234. Severson W.E., Schmaljohn C.S., Javadian A., Jonsson C.B. Ribavirin causes error catastrophe during Hantaan virus replication. J. Virol. 2003, 77:481-488.
235. Severson W., Xu X., Kuhn M., Senutovitch N., Thokala M., Ferron F., Longhi S., Canard B., Jonsson C.B. Essential amino acids of the hantaan virus N protein in its interaction with RNA. J. Virol. 2005, 79:10032-10039.
236. Shi X., Elliott R.M. Golgi localization of Hantaan virus glycoproteins requires coexpression of G1 and G2. Virology 2002, 300:31-38.
237. Shi X., Elliott R.M. Analysis of N-linked glycosylation of hantaan virus glycoproteins and the role of oligosaccharide side chains in protein folding and intracellular trafficking. J. Virol. 2004, 78:5414-5422.
238. Shi X., Lappin D.F., Elliott R.M. Mapping the Golgi targeting and retention signal of Bunyamwera virus glycoproteins. J. Virol. 2004, 78:10793-10802.
239. Shi X., Kohl A., Li P., Elliott R.M. Role of the cytoplasmic tail domains of Bunyamwera orthobunyavirus glycoproteins Gn and Gc in virus assembly and morphogenesis. J. Virol. 2007, 81:10151-10160.
240. Simons J.F., Pettersson R.F. Host-derived 5' ends and overlapping complementary 3' ends of the two mRNAs transcribed from the ambisense S segment of Uukuniemi virus. J. Virol. 1991, 65:4741-4748.
241. Simpson S.Q., Spikes L., Patel S., Faruqi I. Hantavirus pulmonary syndrome. Infect. Dis. Clin. North Am. 2010, 24:159-173.
242. Sironen T., Klingstrom J., Vaheri A., Andersson L.C., Lundkvist A., Plyusnin A. Pathology of Puumala hantavirus infection in macaques. PLoS ONE 2008, 3:e3035.
243. Smallwood S., Moyer S.A. The L polymerase protein of parainfluenza virus 3 forms an oligomer and can interact with the heterologous Sendai virus L, P and C proteins. Virology 2004, 318:439-450.
244. Smallwood S., Cevik B., Moyer S.A. Intragenic complementation and oligomerization of the L subunit of the sendai virus RNA polymerase. Virology 2002, 304:235-245.
245. Song J.W., Baek L.J., Schmaljohn C.S., Yanagihara R. Thottapalayam virus, a prototype shrewborne hantavirus. Emerg. Infect. Dis. 2007, 13:980-985.
246. Song J.W., Kang H.J., Song K.J., Truong T.T., Bennett S.N., Arai S., Truong N.U., Yanagihara R. Newfound hantavirus in Chinese mole shrew, Vietnam. Emerg. Infect. Dis. 2007, 13:1784-1787.
247. Song K.J., Baek L.J., Moon S., Ha S.J., Kim S.H., Park K.S., Klein T.A., Sames W., Kim H.C., Lee J.S., Yanagihara R., Song J.W. Muju virus, a novel hantavirus harboured by the arvicolid rodent Myodes regulus in Korea. J. Gen. Virol. 2007, 88:3121-3129.
248. Spiropoulou C.F. Hantavirus maturation. Hantaviruses 2001, Springer-Verlag, Berlin, Heidelberg. C.L. Schmaljohn, S.T. Nichol (Eds.).
249. Spiropoulou C.F., Morzunov S., Feldmann H., Sanchez A., Peters C.J., Nichol S.T. Genome structure and variability of a virus causing hantavirus pulmonary syndrome. Virology 1994, 200:715-723.
250. Spiropoulou C.F., Goldsmith C.S., Shoemaker T.R., Peters C.J., Compans R.W. Sin Nombre virus glycoprotein trafficking. Virology 2003, 308:48-63.
251. Steitz T.A., Smerdon S.J., Jager J., Joyce C.M. A unified polymerase mechanism for nonhomologous DNA and RNA polymerases. Science 1994, 266:2022-2025.
252. Stohwasser R., Raab K., Darai G., Bautz E.K. Primary structure of the large (L) RNA segment of nephropathia epidemica virus strain Hallnas B1 coding for the viral RNA polymerase. Virology 1991, 183:386-391.
253. Sundstrom J.B., McMullan L.K., Spiropoulou C.F., Hooper W.C., Ansari A.A., Peters C.J., Rollin P.E. Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells. J. Virol. 2001, 75:6070-6085.
254. Taruishi M., Yoshimatsu K., Hatsuse R., Okumura M., Nakamura I., Arikawa J. Lack of vertical transmission of Hantaan virus from persistently infected dam to progeny in laboratory mice. Arch. Virol. 2008, 153:1605-1609.
255. Toh H., Kikuno R., Hayashida H., Miyata T., Kugimiya W., Inouye S., Yuki S., Saigo K. Close structural resemblance between putative polymerase of a Drosophila transposable genetic element 17.6 and pol gene product of Moloney murine leukaemia virus. EMBO J. 1985, 4:1267-1272.
256. Tordo N., Poch O., Ermine A., Keith G., Rougeon F. Completion of the rabies virus genome sequence determination: Highly conserved domains among the L (polymerase) proteins of unsegmented negative-strand RNA viruses. Virology 1988, 165:565-576.
257. Ulmanen I., Seppala P., Pettersson R.F. In vitro translation of Uukuniemi virus-specific RNAs: Identification of a nonstructural protein and a precursor to the membrane glycoproteins. J. Virol. 1981, 37:72-79.
258. Ulrich R., Hjelle B., Pitra C., Kruger D.H. Emerging viruses: The case 'hantavirus'. Intervirology 2002, 45:318-327.
259. Van Epps H.L., Schmaljohn C.S., Ennis F.A. Human memory cytotoxic T-lymphocyte (CTL) responses to Hantaan virus infection: Identification of virus-specific and cross-reactive CD8(+) CTL epitopes on nucleocapsid protein. J. Virol. 1999, 73:5301-5308.
260. Vazquez A.L., Alonso J.M., Parra F. Mutation analysis of the GDD sequence motif of a calicivirus RNA-dependent RNA polymerase. J. Virol. 2000, 74:3888-3891.
261. Vincent M.J., Quiroz E., Gracia F., Sanchez A.J., Ksiazek T.G., Kitsutani P.T., Ruedas L.A., Tinnin D.S., Caceres L., Garcia A., Rollin P.E., Mills J.N., et al. Hantavirus pulmonary syndrome in Panama: Identification of novel hantaviruses and their likely reservoirs. Virology 2000, 277:14-19.
262. Walter C.T., Barr J.N. Bunyamwera virus can repair both insertions and deletions during RNA replication. RNA 2010, 16:1138-1145.
263. Wang H., Strandin T., Hepojoki J., Lankinen H., Vaheri A. Degradation and aggresome formation of the Gn tail of the apathogenic Tula hantavirus. J. Gen. Virol. 2009, 90:2995-3001.
264. Wolf E., Kim P.S., Berger B. MultiCoil: A program for predicting two- and three-stranded coiled coils. Protein Sci. 1997, 6:1179-1189.
265. Worobey M., Holmes E.C. Evolutionary aspects of recombination in RNA viruses. J. Gen. Virol. 1999, 80(Pt. 10):2535-2543.
266. Yamada T., Hjelle B., Lanzi R., Morris C., Anderson B., Jenison S. Antibody responses to Four Corners hantavirus infections in the deer mouse (Peromyscus maniculatus): Identification of an immunodominant region of the viral nucleocapsid protein. J. Virol. 1995, 69:1939-1943.
267. Yang X., Khosravi-Far R., Chang H.Y., Baltimore D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 1997, 89:1067-1076.
268. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 2004, 5:730-737.
269. Yoshimatsu K., Yoo Y.C., Yoshida R., Ishihara C., Azuma I., Arikawa J. Protective immunity of Hantaan virus nucleocapsid and envelope protein studied using baculovirus-expressed proteins. Arch. Virol. 1993, 130:365-376.
270. Yoshimatsu K., Arikawa J., Tamura M., Yoshida R., Lundkvist A., Niklasson B., Kariwa H., Azuma I. Characterization of the nucleocapsid protein of Hantaan virus strain 76-118 using monoclonal antibodies. J. Gen. Virol. 1996, 77(Pt. 4):695-704.
271. Young J.C., Hansen G.R., Graves T.K., Deasy M.P., Humphreys J.G., Fritz C.L., Gorham K.L., Khan A.S., Ksiazek T.G., Metzger K.B., Peters C.J. The incubation period of hantavirus pulmonary syndrome. Am. J. Trop. Med. Hyg. 2000, 62:714-717.
272. Zaki S.R., Greer P.W., Coffield L.M., Goldsmith C.S., Nolte K.B., Foucar K., Feddersen R.M., Zumwalt R.E., Miller G.L., Khan A.S., et al. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am. J. Pathol. 1995, 146:552-579.
273. Zamoto-Niikura A., Terasaki K., Ikegami T., Peters C.J., Makino S. Rift valley fever virus L protein forms a biologically active oligomer. J. Virol. 2009, 83:12779-12789.
274. Zeier M., Handermann M., Bahr U., Rensch B., Muller S., Kehm R., Muranyi W., Darai G. New ecological aspects of hantavirus infection: A change of a paradigm and a challenge of prevention-A review. Virus Genes 2005, 30:157-180.